The global chronic myelomonocytic leukemia (CMML) treatment market is witnessing a period of significant growth. This growth can be attributed to several factors, like the growing incidence of CMML, advancements in therapy, and expanding awareness about the disease. The market is marked by a varied range of treatments available, including targeted